Drug delivery companies develop technologies, formulations and platforms that control how, where and when therapeutic agents are released in the body. The field focuses on improving treatment efficacy, reducing side effects and helping medicines reach their intended targets safely and efficiently.
This category includes companies working on:
Browse 119 UK drug delivery companies below.
Long-acting eye-drop matrix technology for chronic ocular surface disease
Healome Therapeutics is a University of Birmingham spin-out developing a proprietary eye-drop matrix technology that improves drug retention, lubrication and healing on the eye surface. Unlike conventional eye drops, which clear within minutes and often require dosing many times a day, Healome's platform behaves like…
Small molecule drug discovery focused on fibrosis and oncology
Redx Pharma is a clinical-stage biotech developing novel small molecule therapeutics for fibrotic disease and cancer. Its pipeline is anchored by zelasudil, a selective ROCK2 inhibitor in clinical development for idiopathic pulmonary fibrosis and other fibrotic indications, and zamaporvint, a Porcupine inhibitor…
Integrated drug discovery, development and GMP manufacturing CRO
Concept Life Sciences is a contract research organisation delivering integrated drug discovery, development and GMP manufacturing services across facilities in Chapel-en-le-Frith, Edinburgh, Dundee and Sandwich. Its capabilities span medicinal chemistry, translational biology, ADME/DMPK, toxicology and GxP-compliant…
Needle-free solid dose vaccine formulation and delivery platform
aVaxMed Limited is a UK biotech developing the aVaxziPen platform, a proprietary needle-free, thermally stable, solid dose vaccine delivery system. The technology encapsulates vaccine antigens into unit solid doses administered via a pen applicator, removing the need for needles and reducing cold chain requirements.…
Nanotechnology drug delivery platform for precision medicines
Nanomerics is a UK speciality pharmaceutical company developing precision medicines using its proprietary technology, a polymer nanotechnology platform that improves the bioavailability and targeting of water-insoluble drugs and peptides. The technology enables delivery via nasal, ocular, oral, and blood-brain barrier…
Bioactive molecule delivery technologies for cell culture and therapeutics
Cell Guidance Systems is a biotech and reagents company developing technologies for the delivery of bioactive molecules, with applications in cell biology research, drug development, and biomanufacturing. Its technology addresses protein instability in cell culture by providing sustained, localised release of growth…
Year-long subcutaneous drug-releasing implants for chronic disease management
imphatec is a drug delivery company developing subcutaneous implants that release medicines steadily for up to a year, with the aim of replacing daily tablets for people managing chronic and long-term conditions. Its implants are formulated to deliver a customised daily dose of a drug from a polymer matrix placed…
Targeted lipid nanoparticle delivery platform for precision therapeutics
Hone Bio is a preclinical biotechnology company developing targeted lipid nanoparticle drug delivery technology. Its proprietary platform uses engineered proteins that enable cell-specific LNP delivery while actively blocking off-target liver uptake, addressing a key limitation of conventional LNP systems. The…
RBC derived nanoparticles for RNA delivery to brain and immune cells
Crane Biosciences is a biotechnology company developing a non-immunogenic RNA delivery platform based on nanoparticles derived from red blood cell membranes. By using the body's own cellular architecture as a delivery vehicle, the platform achieves substantially higher in vivo delivery efficiency to target tissues…
Stem cell-derived exosome platform for targeted drug delivery
ReNeuron is a biotechnology company developing a stem cell-derived exosome platform for targeted therapeutic delivery. Founded on over two decades of stem cell science, including the world's first clinical trial of conditionally immortalised neural stem cell therapy for stroke disability, the company has pivoted to…
Global CDMO for drug development, delivery and manufacture
Catalent Pharma Solutions is a contract development and manufacturing organisation providing drug development, formulation, and manufacturing services across small molecules, biologics, cell and gene therapies, and consumer health products. The company offers proprietary drug delivery platforms including its orally…
Clinical trial supply, packaging and distribution services
Sharp Services is a contract development and manufacturing organisation providing clinical supply chain services for pharmaceutical and biotechnology companies. Operating from an MHRA-licensed facility in South Wales, the company manages manufacturing, packaging, labelling, storage, and global distribution of…
LNP-mRNA growth factor therapy to restore hearing loss
CamGene Therapeutics is a preclinical biotechnology company developing lipid nanoparticle-delivered mRNA medicines to treat hearing loss at its underlying cellular cause. Its lead approach uses an LNP-mRNA growth factor therapeutic designed to regenerate cochlear nerve cells and reduce inflammation, aiming to restore…
Global medical technology company specialising in chronic condition management
Convatec is a global medical products and technologies company focused on chronic condition management. The group develops and manufactures advanced wound care dressings, ostomy care, continence care and infusion care products, including hydrofiber-based, antimicrobial and tissue-derived biomaterial wound dressings…
Engineered bacterial nanosyringes for intracellular protein delivery
NanoSyrinx is a discovery-stage biotechnology company developing a platform for targeted intracellular delivery of protein and peptide therapeutics. Based on naturally occurring bacterial nanomachines, the company's technology is engineered to deliver biological payloads directly to the cytosol of targeted cells…
Specialist renal pharmaceuticals and clinical nutrition products
Stanningley Pharma is a specialty pharmaceutical company focused on products for patients with chronic kidney disease and other hospital medicine therapeutic areas. The company licenses, develops, and markets prescription medicines and Foods for Special Medical Purposes into the NHS, including a calcium acetate…
AI-driven precision therapeutics for metabolic syndrome diseases
Multiomic Health is a data-centric therapeutics company developing precision medicines for metabolic syndrome-related conditions, including type 2 diabetes, cardiovascular disease, chronic kidney disease and non-alcoholic fatty liver disease. The company integrates multi-omics data with longitudinal clinical datasets…
MHRA-licensed manufacturer of unlicensed medicines and Specials
Arcadia Pharmaceuticals is a licensed contract manufacturer of unlicensed medicines, supplying Specials and Special Obtain products to NHS and pharmacy customers across the UK. Operating from GMP cleanroom facilities in Swansea, the company manufactures a range of dosage forms including oral liquids, topical…
Single-cell genomics and AI platform for autoimmune and fibrotic disease
Ensocell is a Cambridge-based biotechnology company developing precision biologics for autoimmune, inflammatory, and fibrotic diseases. Its platform integrates single-cell and spatial genomics with AI-based computational tools and advanced cell models to identify novel disease intervention points and design targeted…
Clinical-stage biopharma developing treatments for cancer and rare diseases
Biodexa Pharmaceuticals is a Cardiff-based clinical-stage biopharmaceutical company advancing a pipeline of proprietary drug formulations for diseases with high unmet need. Its lead programme, eRapa, an encapsulated oral formulation of rapamycin, is in a Phase 3 registrational trial for familial adenomatous polyposis,…